Warren Hogarth works with energy, healthcare services and software companies. Prior to joining Sequoia Capital in 2008, Warren completed his PhD in Chemical Engineering, where he developed fuel cell technology. During this time, he was a visiting Fulbright Scholar to Princeton University and a Guest Scientist at Germany?s Fraunhofer Institute for Solar Energy Systems. Warren has an MBA from Harvard Business School and a PhD in Chemical Engineering from the University of Queensland.

Roelof Botha works with financial services, cloud computing, bioinformatics, consumer internet and mobile companies. Prior to joining Sequoia Capital in 2003, Roelof served as the Chief Financial Officer of PayPal (EBAY). Earlier, he worked as a management consultant for McKinsey & Company. Roelof is a certified actuary (Fellow of the Institute and Faculty of Actuaries), and has a BS in Actuarial Science, Economics, and Statistics from the University of Cape Town and an MBA from the Stanford Graduate School of Business.

Adam co-founded Keas because after 25 years of building Lego blocks for adults, he thought it was time to spend the next 25 years doing something that mattered. Adam believes that learning from customers is how Keas will continuously improve the way we help people improve their health habits. Adam has typically started and run product teams ranging from Access, XML, and Internet Explorer's AJAX/HTML engine at Microsoft to Google Calendar, Google Spreadsheets, Google Health at Google. Born in London, Adam is father of two boys (one running his own software startup in Beijing and one too young to do anything except enchant) a\ nd a girl studying to be a doctor. Adam is married to the love of his life, Neely.

David Anderson is a Senior Director and Fellow in the Ingenix Innovation Lab. David graduated from the University of Minnesota with a Bachelor of Science degree in Aerospace Engineering. David's career trajectory began in Aeronautical Research and Development before transitioning into clinical informatics in 2001. Since then he has developed applications for fraud detection, clinical trial feasibility, geographic visualization of disease propagation, consumer provider search and others. His database work has lead to presentations at the International Oracle Users Group conference and Netezza's National Users Group confer\ ence. David has won three Ingenix Innovation Awards over the past 6 years and recently was a co-winner in the United Health Group's Innovation Award program.

Currently David's passion is enabling "at scale" signal processing in very large administrative claims data sets. This work has resulted in the Natural History of Disease application which is used for exploring the clinical and financial aspects of any disease by creating and comparing matched cohort populations in our longitudinal claims data. David plans on continuing the "googlization" of the medical discovery process leveraging Netezza's iClass analytic framework.

David Dore is a pharmacoepidemiologist at Innovus Epidemiology in Waltham, MA. Dr. Dore earned a PharmD from the University of Rhode Island and a PhD in epidemiology from Brown Medical School. He completed a post-doctoral fellowship at the Center for Gerontology and Health Care Research at Brown University where his research activities included pharmacoepidemiology and health policy. Dr. Dore's areas of interest are the non-experimental study of drug effects and drug safety. Dr. Dore's work is focused on understanding and using health insurance claims data for etiologic research. His work has been published in several journa\ ls including the Annals of Internal Medicine. He frequently serves as a peer-reviewer, including for the Annals of Internal Medicine and Archives of Internal Medicine. Dr. Dore serves as adjunct faculty at The Warren Alpert Medical School of Brown University where he serves on a doctoral thesis committee, teaches epidemiology to medical students, and leads a course in pharmacoepidemiology for graduate students in epidemiology and health services research.

In his time at Innovus Epidemiology, Dr. Dore has led several post-approval safety studies of drugs and vaccines. Nearly all of his work has been based in commercial health insurance claims data and supplemented with information from abstracted medical records. Two common themes in this work have been the use of advanced techniques to mitigate confounding and misclassification bias. Most of Dr. Dore's research has been in collaboration with industry clients, and in the case of 2 projects, he was tasked with coordination of other research groups, requiring the development of study designs that allowed pooling of aggregate-lev\ el data across sites to preserve patient confidentiality.

Jim Yan is currently Director of Research and Bioinformatics in Labcorp?s Companion Diagnostics Division, where he is focused on biomarker development and validation. He has 12 year industrial experience, mostly in bioinformatics and genomics. Prior to Labcorp, he was Vice President of R&D and Bioinformatics at CancerGuide Diagnostics, Inc, leading its effort in evaluation and co-development of biomarkers for pathway targeted cancer therapy. As a group leader in Almac Diagnostics, a British company, Jim built and led the US team of Senior bioinformaticians and biostatisticians and accomplished many genomics and biomarker projects and software initiatives. He started his industrial career in DuPont in 1999 and led a group in providing bioinformatics support for genomics projects. During his seven-year tenure at DuPont, he had extensive exposure to evolution of different types of genomics technology and large projects, and experience in research informatics, data analysis and integration, predictive modeling and data mining for a large R&D organization.

Jim received a Ph.D. in Biochemistry from The University of Texas at Austin in 1995, did his postdoctoral training in computational biology and pharmacology at The University of Texas Southwestern Medical Center in Dallas and received NIH Individual Research Service Award. Jim also holds an MBA from University of Iowa Tippie School of Management as well as a MS in Biophysics from Chinese Academy of Sciences.

David McCallie, Jr., MD, vice president, Medical Informatics, is director of the Cerner Medical Informatics Institute. He is responsible for a research and development team focused on developing innovations at the intersection of computer science and clinical medicine. His most recently completed project was the design of Cerner?s ePrescribing system and the Community Health Record. He is currently working on the definition of the next generation of personal health records, known as Independent Health Record Trusts.

Dr. McCallie joined Cerner in 1991. He was previously responsible for the development of Cerner?s clinical nomenclature system and the PowerNote? structured clinical documentation tool. He also was the chief architect for open clinical foundation, Cerner?s clinical data repository. He is a member of Cerner?s architecture cabinet.

Prior to joining Cerner, McCallie was director of research computing at Children?s Hospital in Boston, Mass., and an instructor in neurology at Children?s Hospital and Harvard Medical School. His research background includes using computers to create three-dimensional models of seizure-induced brain electrical activity. McCallie earned a bachelor?s degree in electrical engineering and computer science at Duke University. He earned his medical degree at Harvard Medical School. McCallie has published numerous articles and presented frequently on the subject of healthcare informatics. He is a member of the American Medical Informatics Association.

Andreas is an expert on the analysis of ultra high-throughput DNA sequence data and has published methods in whole-genome mammalian assembly, metagenomics, and population genetics. Andreas received his Bachelor's and Master's degrees in Electrical Engineering and Computer Science from MIT, and his Ph.D. in Computer Science from Stanford University.

Ramon Bio

While working at a cholera clinic in Bangladesh, Nadim witnessed how profound lapses in healthcare communication routinely cost patients their lives. Since then, he has sought to explore the intersection between public health, medicine, and mobile technology. He graduated from Yale with a B.S./M.S. in Molecular Biophysics and Biochemistry, is a current medical student at Stanford University, and a public health student at Columbia?s Mailman School of Public Health. He is a Bates Fellow, Rita F. Wyman Fellow, and a Peter J. Sharp Fellow. Nadim works to spearhead research partnerships, demonstrate the impact of our tools, and \ coordinate research internships through Medic Mobile.